Sugi Predict

Sugi Predict / Compounds / SCHEMBL1325334

SCHEMBL1325334

SCHEMBL1325334

S=C=Nc1ccccc1I

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.52
▸ CYP3A4 P08684 2/20 0.52
▸ HPGD P15428 2/20 0.52
▸ ABCB11 O95342 1/20 0.52
▸ NR3C1 P04150 1/20 0.52
▸ CYP1A2 P05177 1/20 0.52
▸ ADRA2A P08913 1/20 0.52
▸ ADORA3 P0DMS8 1/20 0.52
▸ ALOX15 P16050 1/20 0.52
▸ ADRA2C P18825 1/20 0.52
▸ MAOA P21397 1/20 0.52
▸ DRD1 P21728 1/20 0.52
▸ SLC6A4 P31645 1/20 0.52
▸ HTR2B P41595 1/20 0.52
▸ CCR2 P41597 1/20 0.52
▸ HSD17B10 Q99714 1/20 0.52
▸ TDP1 Q9NUW8 1/20 0.52
▸ MIF P14174 5/20 0.46
▸ APLNR P35414 1/20 0.44
▸ POLB P06746 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30876056 1.00 ALDH1A1 (0.52) ALDH1A1CYP3A4HPGDABCB11NR3C1
SCHEMBL29374052 0.82 ALDH1A1 (0.62) ALDH1A1CYP3A4HPGDABCB11NR3C1
SCHEMBL207554 0.82 ALDH1A1 (0.62) ALDH1A1CYP3A4HPGDABCB11NR3C1
SCHEMBL31398331 0.76 SIGMAR1 (0.36) SIGMAR1GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL93319 0.76 CYP3A4 (0.52) ALDH1A1CYP3A4HPGDTDP1SIGMAR1
SCHEMBL4466979 0.75 ALDH1A1 (0.56) ALDH1A1CYP3A4HPGDABCB11NR3C1
SCHEMBL11569821 0.72 ALDH1A1 (0.40) ALDH1A1CYP3A4HPGDABCB11NR3C1
SCHEMBL24660121 0.71 ALDH1A1 (0.52) ALDH1A1CYP3A4HPGDABCB11NR3C1
SCHEMBL484005 0.71 CYP3A4 (0.52) ALDH1A1CYP3A4HPGDABCB11NR3C1
SCHEMBL458499 0.71 ALDH1A1 (0.52) ALDH1A1CYP3A4HPGDABCB11NR3C1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 119 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117820337-A Preparation method of 12H-benzo [4,5] thiazolo [2,3-b ] quinazoline 12-ketone compound 赣南师范大学 2024-04-05 — — CN claimed
CN-113861223-B Synthesis method and application of thiazolo [3,2-a ] benzimidazole compound 暨南大学 2022-09-16 — — CN claimed
CN-113861223-A Synthesis method and application of thiazolo [3,2-a ] benzimidazole compound 暨南大学 2021-12-31 — — CN claimed
CN-117820337-B Preparation method of 12H-benzo [4,5] thiazolo [2,3-b ] quinazoline 12-ketone compound 赣南师范大学 2026-04-03 — — CN disclosed
US-20250282796-A1 PENEM ANTIBACTERIALS AGAINST MYCOBACTERIAL PATHOGENS AND D,D- AND L,D TRANSPEPTIDASES THE JOHNS HOPKINS UNIVERSITY 2025-09-11 — — US disclosed
US-12297209-B2 Benzodiazepine derivatives as RSV inhibitors ENANTA PHARMACEUTICALS, INC. (US) 2025-05-13 — — US disclosed
US-12268694-B2 Combination pharmaceutical agents as RSV inhibitors ENANTA PHARMACEUTICALS, INC. (US) 2025-04-08 — — US disclosed
US-20240360155-A1 Benzodiazepine Derivatives as RSV Inhibitors ENANTA PHARM INC (US) 2024-10-31 — — US disclosed
US-11952389-B2 Benzodiazepine derivatives as RSV inhibitors ENANTA PHARMACEUTICALS, INC. (US) 2024-04-09 — — US disclosed
CN-117820337-A Preparation method of 12H-benzo [4,5] thiazolo [2,3-b ] quinazoline 12-ketone compound 赣南师范大学 2024-04-05 — — CN disclosed
CN-117820337-A Preparation method of 12H-benzo [4,5] thiazolo [2,3-b ] quinazoline 12-ketone compound 赣南师范大学 2024-04-05 — — CN disclosed
EP-1060377-A2 REAGENTS AND METHODS FOR PROTEIN MICROSEQUENCING Biotraces Inc. (US) 2000-12-20 — — EP disclosed
WO-1999049292-A2 REAGENTS AND METHODS FOR PROTEIN MICROSEQUENCING BIOTRACES, INC. (US) 1999-09-30 — — WO disclosed
US-5393883-A Ribonucleotide reductase inhibitors BURROUGHS WELLCOME CO. (US) 1995-02-28 — — US disclosed
US-5175165-A Acyclovir and a thiocarbonohydrazone ribonucleotide reductase inhibitor for treatment of herpes virus BURROUGHS WELLCOME CO. (US) 1992-12-29 — — US disclosed
EP-0349243-B1 ANTIVIRAL COMBINATIONS AND COMPOUNDS THEREFOR THE WELLCOME FOUNDATION LIMITED (GB) 1992-04-01 — — EP disclosed
EP-0349243-A2 Antiviral combinations and compounds therefor THE WELLCOME FOUNDATION LIMITED (GB) 1990-01-03 — — EP disclosed
US-4134914-A 1-Acyl-4-substituted phenyl thiosemicarbazides ELI LILLY AND COMPANY (US) 1979-01-16 — — US disclosed
US-4082762-A 4-(2-HALOPHENYL)-1,2,4-TRIAZOLE-3-THIOL COMPOUNDS ELI LILLY AND COMPANY (US) 1978-04-04 — — US disclosed
US-3937713-A Process for the preparation of s-triazolo[3,4-b]benzothiazoles ELI LILLY AND COMPANY (US) 1976-02-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240360155-A1 Benzodiazepine Derivatives as RSV Inhibitors GABRA5, GABRA1, GABBR2 ALDH1A1 621/4885CYP3A4 24/4885HPGD 869/4885
US-20250282796-A1 PENEM ANTIBACTERIALS AGAINST MYCOBACTERIAL PATHOGENS AND D,D- AND L,D TRANSPEPTIDASES PEPD, DNPEP, NAALAD2 ALDH1A1 1945/4885CYP3A4 2516/4885HPGD 1158/4885
US-11952389-B2 Benzodiazepine derivatives as RSV inhibitors GABRA5, GABRA1, GABBR2 ALDH1A1 621/4885CYP3A4 24/4885HPGD 869/4885
US-12297209-B2 Benzodiazepine derivatives as RSV inhibitors GABRA5, GABRA1, GABBR2 ALDH1A1 621/4885CYP3A4 24/4885HPGD 869/4885
US-12268694-B2 Combination pharmaceutical agents as RSV inhibitors ACE, ACE2, SPCS3 ALDH1A1 4172/4885CYP3A4 3234/4885HPGD 2245/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.